CHD7 and gastric cancer: On the other hand, low CHD7 levels correlate with an enhanced survival rate of patients with pancreatic tumor (Colbert et al., 2014), and loss-of-function mutations of CHD7 are reported in colorectal as well as gastric cancer (Kim et al., 2011; Tahara et al., 2014).